Medical Marijuana, Inc., parent company of direct selling brand Kannaway, announced it has entered into an Asset Purchase Agreement with MFINITY, Global, LLC, a direct selling organization that promotes natural health.
Kannaway, the direct selling subsidiary of Medical Marijuana, Inc., recently participated in an industry-led cannabidiol (CBD) Safety Study, for which Validcare acted as CRO.
The South African division of Kannaway, the direct selling subsidiary of Medical Marijuana, Inc., achieved its largest revenue month in the company’s history for this region during March 2022. “2022 has been a truly remarkable year for sales in South Africa so far,” said Medical Marijuana, Inc. CEO Blake Schroeder. “We’re excited about our very […]
Kannaway, the direct selling subsidiary of Medical Marijuana, Inc., has been included in the list of brands who have submitted Novel Foods applications to the UK Food Standard Agencies (FSA). Brands included on this list may continue to market their products within the UK, while those who were excluded must discontinue sales. These Kannaway cannabidiol […]
Kannaway, the direct selling subsidiary of Medical Marijuana, Inc., announced that its Japan and South Africa divisions reached their largest revenue month in company history during January 2022.
Kannaway, the direct selling subsidiary of Medical Marijuana, Inc., has opened a 3,326 square foot combined office and warehouse in Johannesburg, South Africa. The new facility will allow Kannaway to ship the company’s full line of products throughout the country.
Kannaway, the direct selling subsidiary of Medical Marijuana, Inc., announced the opening of a new office and warehouse in Warsaw, Poland.
This new revenue benchmark breaks a previous record set in September of 2021 for highest revenue within the division.
Leading this expansion will be Duduzile Mathole, a direct selling industry veteran with experience in the local and regional regulations of South Africa regarding cannabis, who has been hired as Country Manager, South Africa.
Medical Marijuana, Inc., the parent company of direct selling organization Kannaway, announced a gross profit of $6.7 million and net revenue of $9.2 million for the third quarter of 2021.
Although the company has had an active presence in Finland for years, Finnish Customs confiscated a bottle of Kannaway Pure Gold in 2018, claiming it was illegally imported.
Kannaway, a direct selling subsidiary of Medical Marijuana, Inc., was recently honored at the 2021 CEO Awards with a Gold Globee for Executive Achievement of the Year in the Consumer Products category, an award given to organizations who set industry benchmarks for excellence.